Prof. Ferguson, when you were recently appointed to direct SFI, local newspapers ran headlines such as “New SFI head to drive economic impact from research investments.”…
In Conversation
One of the most drastic changes the healthcare industry has faced recently is the phenomenal growth of generics in the Mexican market. Which solutions does DHL…
What initially attracted you to Biotest back in 2001 and what do you think attracts industry professionals to Biotest today? I started my pharmaceutical career at…
You previously worked as CSO for onepharm; what was the motivation for creating Savira? OS: When I was working at onepharm, the organization was focused on…
If we had to run shy of being competitive, I don’t believe that we would be driving in the right lane in this industry.'
Mr. Leahy, you worked for Servier for nearly a decade before joining Takeda. What have been the chief differences you have noticed between the smaller, independent,…
“ With an evident recession and cost-cutting measures abound Ms. Nolan elaborates on the new plain on which pharmaceutical players have found themselves upon and how they… ”
Novo Nordisk is primarily known as the premier global diabetes player—so let us begin by examining the realities of diabetes in Ireland. In 2012, the International…
Speaking to the Australian environment, how would you rate the market in terms of companies like Swisse? After traveling the world, the Australian market has shown…
In our interviews we have been hearing two opinions on the success of PBS reforms: that it works as it should in providing space for innovative…
Dr Bernadette Morris-Smith has also participated in this interview TranScrip Partners is by now a well-established player in the UK but a new player in Asia…
“Australia is not just a postbox for selling drugs; Celgene is committed to establishing a major presence in the region,” you said when Focus Reports met…
